Cerebrolysin
5ml · 99%+ Purity
HPLC Tested
99%+ Purity
About Our Testing
Every batch is tested by our manufacturer using HPLC analysis. Per-batch third-party testing adds significant cost and delays that would be passed to customers.
Fast Shipping
Same-day dispatch
Description
Cerebrolysin is a peptide mixture with neurotrophic-like effects, studied for its potential to support neuronal survival and synaptic plasticity. Research explores its impact on cognitive function and neurodegenerative conditions like Alzheimer's.
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.
Research & Science
Evidence-based information about this compound
Cerebrolysin is a peptide preparation derived from pig brain tissue through enzymatic breakdown. It contains a complex mixture of low-molecular-weight neuropeptides (less than 10 kDa) and free amino acids that can cross the blood-brain barrier.
The preparation includes fragments of neurotrophic factors and other brain-derived compounds that have demonstrated neurotrophic and neuroprotective properties. It has been used clinically for decades in many countries for various neurological conditions.
Cerebrolysin represents a multi-target approach to neurological support, with its complex composition affecting multiple pathways simultaneously.
Cerebrolysin's effects stem from multiple mechanisms:
- Neurotrophic Support: Contains fragments with neurotrophic factor-like activity.
- Neuroplasticity: Enhances synaptic plasticity and dendritic spine formation.
- Neuroprotection: Protects neurons from various forms of damage.
- Anti-Apoptotic: Reduces programmed cell death in neurons.
- Neurogenesis: May support new neuron formation in certain regions.
Cerebrolysin's neurotrophic effects are well-documented:
- Neurite Outgrowth: Promotes growth of neuronal processes in cell cultures.
- Synaptogenesis: Enhances formation of new synaptic connections.
- Brain Repair: Supports neuronal survival and repair mechanisms.
- Cognitive Function: Associated with improved cognitive outcomes in clinical studies.
These effects underlie its use in neurodegenerative and neurological injury research.
Cerebrolysin has extensive clinical research:
- Stroke Recovery: Multiple trials in acute ischemic stroke.
- Alzheimer's Disease: Studied for cognitive improvement in AD patients.
- Traumatic Brain Injury: Research in TBI recovery.
- Vascular Dementia: Investigated for cognitive support.
It is approved in numerous countries for neurological conditions.
Sources:
This information is provided for educational purposes only and is based on published scientific research. This product is intended for research use only.
